Literature DB >> 11943852

Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus.

F Susan Wong1, Antonis K Moustakas, Li Wen, George K Papadopoulos, Charles A Janeway.   

Abstract

The recognition of MHC-peptide complexes by T cells is governed by structural considerations that are determined by the sequences of the individual components and their interaction with each other. We have studied the function of a highly diabetogenic CD8 T cell clone that is specific for insulin B15-23:H-2K(d). We have then related this to modeled MHC-peptide structures. The native peptide binds poorly to H-2K(d), because of the small glycine residue at peptide position p9 that is incapable of productive interactions with the hydrophobic residues of pocket F. In addition, electrostatic repulsions between the peptide glutamate residue at position 7 and 152D of the MHC molecule heavy chain contribute to the poor binding. However, B chain peptide 15-23 bound to K(d) shows excellent T cell stimulation and the induction of CD8 cytotoxic T cells. Peptide substitution has also shown that p6G is likely to be a T cell antigen receptor interaction site. Our studies have shown that the predictions seen in the models correlate closely with the observed effects in functional assays and provide insight into how this peptide, which would not be predicted to stimulate these cells on H-2K(d) binding studies alone, could activate such highly pathogenic T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943852      PMCID: PMC122807          DOI: 10.1073/pnas.072037299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors:  F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

2.  Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs.

Authors:  A Pugliese; D Brown; D Garza; D Murchison; M Zeller; M J Redondo; M Redondo; J Diez; G S Eisenbarth; D D Patel; C Ricordi
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

3.  Modelling of the MHC II allele I-A(g7) of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule.

Authors:  A K Moustakas; J Routsias; G K Papadopoulos
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

Review 4.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization.

Authors:  S K Burley; G A Petsko
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

5.  Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.

Authors:  M Moriwaki; N Itoh; J Miyagawa; K Yamamoto; A Imagawa; K Yamagata; H Iwahashi; H Nakajima; M Namba; S Nagata; T Hanafusa; Y Matsuzawa
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

6.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

Authors:  R R Latek; A Suri; S J Petzold; C A Nelson; O Kanagawa; E R Unanue; D H Fremont
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

7.  Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route.

Authors:  A Hänninen; A Braakhuis; W R Heath; L C Harrison
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

8.  Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

Authors:  R K Sibley; D E Sutherland; F Goetz; A F Michael
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

9.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

10.  A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin.

Authors:  D G Alleva; P D Crowe; L Jin; W W Kwok; N Ling; M Gottschalk; P J Conlon; P A Gottlieb; A L Putnam; A Gaur
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more
  28 in total

1.  Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

Authors:  Maki Nakayama; Joshua N Beilke; Jean M Jasinski; Masakazu Kobayashi; Dongmei Miao; Marcella Li; Marilyne G Coulombe; Edwin Liu; John F Elliott; Ronald G Gill; George S Eisenbarth
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

3.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

4.  Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Authors:  Gayatri Mukherjee; Rodolfo J Chaparro; Jennifer Schloss; Carla Smith; Christopher D Bando; Teresa P DiLorenzo
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

5.  Antibodies to post-translationally modified insulin in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Mayda H Arshad; David Perrett; Claudio Tiberti; Francesco Chiarelli; Nicola Napoli; Paolo Pozzilli; Ahuva Nissim
Journal:  Diabetologia       Date:  2015-09-08       Impact factor: 10.122

6.  Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.

Authors:  Sigal Fishman; Mark D Lewis; L Khai Siew; Evy De Leenheer; Dimitri Kakabadse; Joanne Davies; Doron Ziv; Alon Margalit; Nathan Karin; Gideon Gross; F Susan Wong
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

7.  Identification of novel IGRP epitopes targeted in type 1 diabetes patients.

Authors:  Irene Jarchum; Lynn Nichol; Massimo Trucco; Pere Santamaria; Teresa P DiLorenzo
Journal:  Clin Immunol       Date:  2008-03-20       Impact factor: 3.969

8.  Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.

Authors:  Nathan R Martinez; Petra Augstein; Antonis K Moustakas; George K Papadopoulos; Silvia Gregori; Luciano Adorini; David C Jackson; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.

Authors:  E Nikoopour; O Krougly; E Lee-Chan; S M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

10.  Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.

Authors:  Liliana G Petrich de Marquesini; Antonis K Moustakas; Ian J Thomas; Li Wen; George K Papadopoulos; F Susan Wong
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.